GlassScriptPhysician profile
Shalini Sangal
NPI 1689660896
$2,846.69
in general payments reported to CMS, 2019-2025
13 companies · $599 in 2025
The $599 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $135 · 2021: $169 · 2022: $317 · 2023: $690 · 2024: $628 · 2025: $599.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,917.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $527.13 | 2019-2025 | Invega Sustenna, Spravato, Invega Trinza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $494.45 | 2022-2025 | Caplyta |
| Alkermes, INC. | $486.40 | 2019-2025 | Aristada, Lybalvi, Aristada Initio |
| Otsuka America Pharmaceutical, INC. | $401.47 | 2019-2025 | Abilify Maintena, Abilify Asimtufii, Rexulti |
| Indivior INC. | $391.45 | 2022-2024 | Perseris, Sublocade |
| E.R. Squibb & Sons, L.L.C. | $220.19 | 2024-2025 | Cobenfy |
| Abbvie INC. | $163.39 | 2021-2024 | Vraylar |
| Allergan, INC. | $39.43 | 2020 | |
| Janssen Biotech, INC. | $37.54 | 2023 | |
| Lundbeck LLC | $31.43 | 2019-2022 | |
| Sight Sciences, INC. | $22.43 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $15.73 | 2023 | Uzedy |
| Vanda Pharmaceuticals INC. | $15.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shalini Sangal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.